trending Market Intelligence /marketintelligence/en/news-insights/trending/c8p9x8uqayuydd6w38vaxa2 content esgSubNav
In This List

Knight acquires Crescita shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Knight acquires Crescita shares

Knight Therapeutics Inc. said it acquired an additional 754,716 shares of Crescita Therapeutics Inc. for C$400,000.

The Canadian specialty pharmaceutical company participated in Crescita's rights offering to raise C$3.7 million via the sale of 7,001,603 shares.

Knight Therapeutics now owns 2,834,689 shares of Crescita, representing 13.5% of the company. It previously owned 2,079,973 shares representing 14.9% of Crescita; its ownership has diluted as a result of the latest rights offering.

Knight's ownership in Crescita is for investment purposes.